<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01578421</url>
  </required_header>
  <id_info>
    <org_study_id>HD-FX-01-CH</org_study_id>
    <nct_id>NCT01578421</nct_id>
  </id_info>
  <brief_title>Investigation on the Middle Size Molecule Elimination Characteristics of the FXCorDiax 100 in Relation to the FX 100 and the Polyflux 210 H Dialyser</brief_title>
  <official_title>Investigation on the Middle Size Molecule Elimination Characteristics of the FXCorDiax 100 in Relation to the FX 100 and the Polyflux 210 H Dialyser</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kantonsspital Aarau</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fresenius Medical Care Deutschland GmbH</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Kantonsspital Aarau</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to compare clearance and removal rates of phosphate,
      ß2-microglobulin (ß2-m) and leptin and albumin loss with different dialyser membranes during
      post-dilution online hemodiafiltration.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2012</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">September 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clearance and removal rate of phosphate, beta2 microglobulin and leptin</measure>
    <time_frame>4 hour</time_frame>
    <description>during a 4 hour online hemodiafiltration session</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">31</enrollment>
  <condition>Renal Failure Chronic Requiring Hemodialysis</condition>
  <arm_group>
    <arm_group_label>FX 100 dialyzer</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Polyflux 210 H dialyzer</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>FXCorDiax 100 dialyzer</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>4 h online hemodiafiltration (FX 100, Polyflux 210, FXCorDiax)</intervention_name>
    <description>4 h online hemodiafiltration with measurement of clearance and removal rate by split dialysate collection and bloodside measurements</description>
    <arm_group_label>FX 100 dialyzer</arm_group_label>
    <arm_group_label>Polyflux 210 H dialyzer</arm_group_label>
    <arm_group_label>FXCorDiax 100 dialyzer</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  hemodialysis patients 18 years and older

          -  treated by post dilution on-line Hemodiafiltration (HDF) for at least one month

          -  who reached a dialysis dose (Kt/V) of at least 1.2 at each of the last two monthly
             checks

          -  who are on a stable anticoagulation and anemia management

          -  whose hemoglobin is between 10.5 and 13.0 g/dl

          -  who are clinically stable based on judgment of nephrologist

          -  who are on a regular thrice weekly HDF schedule, e.g. Monday-Wednesday-Friday or
             Tuesday-Thursday-Saturday,

          -  who have a good vascular access (fistula or graft) which enables easy insertion of the
             needles and suitable effective blood flow (&gt; 300 ml/min)

          -  who are able to understand the nature and requirements of the clinical investigation
             and who have given written informed consent

        Exclusion Criteria: Patients

          -  with active Hepatitis B, Hepatitis C or HIV infection

          -  who are severely malnourished as judged by the principal investigator

          -  who are known or suspected to have allergy to the trial products or related products

          -  with a central venous catheter based vascular access

          -  who are abusing non-legal drugs or alcohol

          -  who have currently active malignant disease

          -  who are female of child-bearing age without effective measures of contraception,
             pregnant or breastfeeding

          -  who participate simultaneously in another clinical investigation

          -  who have participated in othe clinical investigations during the last month

          -  who are uncooperative
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andreas Bock, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nephrology Division, Kantonsspital Aarau</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Nephrology Division, Kantonsspital Aarau</name>
      <address>
        <city>Aarau</city>
        <zip>CH-5001</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <link>
    <url>http://www.ksa.ch/nephrologie</url>
    <description>Website of the Kantonsspital Aarau Nephrology Division</description>
  </link>
  <verification_date>August 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 12, 2012</study_first_submitted>
  <study_first_submitted_qc>April 16, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 17, 2012</study_first_posted>
  <last_update_submitted>August 6, 2013</last_update_submitted>
  <last_update_submitted_qc>August 6, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 7, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kantonsspital Aarau</investigator_affiliation>
    <investigator_full_name>Andreas Bock</investigator_full_name>
    <investigator_title>Prof. Andreas Bock, Chefarzt Nephrologie</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Renal Insufficiency</mesh_term>
    <mesh_term>Kidney Failure, Chronic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

